• Male and female subjects ages 2 to 17 years with clinical diagnosis of chronic plaque psoriasis and stable disease for at least 3 months prior to the baseline visit

• Subject with plaque psoriasis covering ≥ 3% of the BSA at screening and baseline

• A PGA score of ≥ 2 at screening and baseline

• Female subjects of childbearing potential who are engaging in sexual activity that could lead to pregnancy should use acceptable birth control methods

• Must not be pregnant

• Subject, subject's parent, or legal representative must be capable of giving written informed consent/assent